Hi 007, thanks for the excellent postings on EYE which I love reading. I have been a shareholder for 15+ years, originally investing in ELX. I have never sold any shares but keep accumulating when there are good lows, such as 21.5c just a few days ago. I am very optimistic a big payday is coming.
On a technical point you posted at the start of the thread :
"The most versatile MIGS procedure. Can be used for a number of different types of procedures (ab interno, ab externo etc) and is able to treat significantly more types of glaucoma, most notably, closed angle glaucoma (which no other device is able to treat)."
Can you explain why no other device can treat closed angle glaucoma? I love this story but wondering how robust our advantage is and how secure our moat is for this new treatment option which is massive in market size?
Hi 007, thanks for the excellent postings on EYE which I love...
-
- There are more pages in this discussion • 296 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $48.10M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.5¢ | 21.0¢ | $45.70K | 217.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2722 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 57356 | 2 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| EYE (ASX) Chart |